1773489-72-7
1773489-72-7
Chemical Structure
Nidufexor
Synonym(s): LMB763
- CAS No.: 1773489-72-7
- Formula:C27H22ClN3O4
- Molecular Weight:487.93
IUPAC Name: 4-((N-benzyl-8-chloro-1-methyl-1,4-dihydrochromeno[4,3-c]pyrazole-3-carboxamido)methyl)benzoic acid
InChIKey: JYTIXGYXBIBOMN-UHFFFAOYSA-N
SMILES: CN1C(C2=CC(Cl)=CC=C2OC3)=C3C(C(N(CC4=CC=CC=C4)CC5=CC=C(C(O)=O)C=C5)=O)=N1
Biological Activity: Nidufexor (LMB763) is an orally-available farnesoid X receptor (FXR) agonist for the research of nonalcoholic steatohepatitis (NASH)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Nidufexor | 99.65% | Nidufexor (LMB763) is an orally-available farnesoid X receptor (FXR) agonist for the research of nonalcoholic steatohepatitis (NASH). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Nidufexor (Standard) | ≥98% | Nidufexor (Standard) is the analytical standard of Nidufexor (HY-109096). This product is intended for research and analytical applications. Nidufexor (LMB763) is an orally-available farnesoid X receptor (FXR) agonist for the research of nonalcoholic steatohepatitis (NASH). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
